Source:
Newly released NIH documents show conclusively that statements made during congressional hearings to U.S. Sen. Rand Paul (R-KY) and Rep. John Moolenaar (R-MI) by NIH leaders Anthony Fauci and Lawrence Tabak were misleading, if not outright false, regarding third-party royalties paid before, during, and after the pandemic.
Tabak, acting director of the National Institutes of Health, and Fauci, then-director of the National Institutes of Allergies and Infectious Diseases, both claimed before Congress that they could not release the names of the companies paying NIH third party royalties.
Last week, however, our OpenTheBooks lawsuit based on our Freedom of Information Act request caused NIH to release new documents.
The newly released documents reveal – for the first time – the names of companies that paid NIH scientists $325 million in third party royalties from 56,000 transactions between September 2009 and October 2020.
Our OpenTheBooks oversight reporting — which led to three congressional hearings during 2022 regarding NIH’s secret third party royalty payments — is available here for review.
Here are some key findings from the new disclosures:
- In U.S. Senate hearings during 2022, Dr. Anthony Fauci refused to disclose the companies who licensed his “inventions” and paid his third-party royalties. Finally, now, we know the companies paying him. They are listed below.
- Chinese government-owned pharmaceutical companies, controlled by the Chinese Communist Party (CCP), paid the National Institutes of Health (NIH) third-party royalties to license technologies developed on the U.S. taxpayer dime. One such company neighbors the Wuhan Institute of Virology, collaborates with the lab, and even paid a royalty to Douglas Lowy, a multiple term acting director at the National Cancer Institute, a sub-institute of NIH.
- Russian animal vaccine maker – which was allegedly a front for a Soviet bio-weapons lab – licensed inventions and paid royalties to NIH for tech developed with taxpayer dollars.
- Purdue Pharma – the makers of the highly addictive and frequently abused OxyContin (oxycodone) – licensed tech developed with public funds and paid royalties to NIH – even after the company pleaded guilty to federal crimes relating to opioids.
- Long-serving former NIH director, Francis Collins, received third party royalties on his inventions from four companies that themselves received nearly $50 million in federal contracts and grants since 2008.
During the pandemic, the American people started to worry that Big Government was too close to Big Pharma. Now, because of our oversight investigation at OpenTheBooks.com, we know just how close they are: NIH spends billions on the industry and now we know the industry sends millions back to NIH and its scientists….